Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. E. Cabozantinib *** > (*) USA Approval Date: 2017. 12.20>

---

Previously Untreated First Line Treat.


(*) USA Approval Date: 2017. 12.20>'s products
This section has no products